![Paul Rennie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Rennie
Vorstandsvorsitzender bei
PARADIGM BIOPHARMACEUTICALS LIMITED
Vermögen: 2 Mio $ am 30.06.2026
Profil
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., where he currently holds the title of Executive Chairman & Managing Director.
Paradigm Biopharmaceuticals Ltd. was founded in 2014.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd. as Non-Executive Chairman, Stiefel Research Australia Pty Ltd. as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd. as Manager-Business Development, Mesoblast Ltd. as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd. as Manager-Sales & Marketing.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 21.409.425 ( 3,66 % ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Paul Rennie
| Unternehmen | Position | Beginn |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Vorstandsvorsitzender | 22.11.2022 |
Ehemalige bekannte Positionen von Paul Rennie
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Vorstandsvorsitzender | 11.09.2023 |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Develops delivery systems for new dermatology products | Corporate Officer/Principal | - |
| MERCK KGAA | Vertrieb & Marketing | - |
Roche Diagnostics Australia Pty Ltd. | Vertrieb & Marketing | - |
| MESOBLAST LIMITED | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Manufactures dairy products and ingredients | Distribution Services |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Develops delivery systems for new dermatology products | Health Technology |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Roche Diagnostics Australia Pty Ltd. | |
Paradigm Biopharmaceuticals Ltd.
 Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
Neuroscientific Biopharmaceuticals Ltd.
 Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Wählen Sie MarketScreener 
